Imaging of liver metastases: MRI

Cancer Imaging

Volumn 7, Issue 1, 2007, Pages 2-9

  Namasivayam, Saravanan ^a,b   Martin, Diego R ^a   Saini, Sanjay ^a,b  

^a EMORY UNIVERSITY HOSPITAL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Liver metastasis; Magnetic resonance imaging

Indexed keywords

CONTRAST MEDIUM; GADOBENATE DIMEGLUMINE; GADOBENIC ACID; GADOLINIUM CHELATE; GADOXETIC ACID; IODINATED CONTRAST MEDIUM; IRON OXIDE; MANGAFODIPIR; SUPERPARAMAGNETIC IRON OXIDE;

ARTICLE; BENIGN TUMOR; BREAST CARCINOMA; CARCINOID; COLON CARCINOMA; CONTRAST ENHANCEMENT; DIFFUSION WEIGHTED IMAGING; DRUG EXCRETION; DRUG HYPERSENSITIVITY; DRUG SAFETY; HUMAN; INCIDENTAL FINDING; KIDNEY CARCINOMA; KIDNEY FAILURE; LIVER METASTASIS; LUNG CARCINOMA; MELANOMA; NEUROENDOCRINE TUMOR; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS ISLET CELL TUMOR; RADIATION EXPOSURE; SENSITIVITY AND SPECIFICITY; STOMACH CARCINOMA; THYROID CARCINOMA; TUMOR VASCULARIZATION; LIVER TUMOR; METASTASIS; METHODOLOGY; REVIEW;

CONTRAST MEDIA; HUMANS; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING;

EID: 34249726798     PISSN: None     EISSN: 14707330     Source Type: Journal    
DOI: 10.1102/1470-7330.2007.0002     Document Type: Article

References (31)

1. Imam K, Bluemke DA. MR imaging in the evaluation of hepatic metastases. Magn Reson Imaging Clin N Am 2000; 8: 741-56.
2. Ward J. New MR techniques for the detection of liver metastases. Cancer Imaging 2006; 6: 33-42.
3. Rummeny EJ, Marchal G. Liver imaging. Clinical applications and future perspectives. Acta Radiol 1997; 38: 626-30.
4. Semelka RC, Cance WG, Marcos HB, Mauro MA. Liver metastases: comparison of current MR techniques and spiral CT during arterial portography for detection in 20 surgically staged cases. Radiology 1999; 213: 86-91.
5. Soyer P, Levesque M, Caudron C, Elias D, Zeitoun G, Roche A. MRI of liver metastases from colorectal cancer vs. CT during arterial portography. J Comput Assist Tomogr 1993; 17: 67-74.
6. Schima W, Kulinna C, Langenberger H, Ba-Ssalamah A. Liver metastases of colorectal cancer: US, CT or MR? Cancer Imaging 2005; 5A: S149-56.
7. Saini S, Nelson RC. Technique for MR imaging of the liver. Radiology 1995; 197: 575-7.
8. Martin DR, Danrad R, Hussain SM. MR imaging of the liver. Radiol Clin North Am 2005; 43: 861-86, viii.
9. Martin DR, Friel HT, Danrad R, De Becker J, Hussain SM. Approach to abdominal imaging at 1.5 Tesla and optimization at 3 Tesla. Magn Reson Imaging Clin N Am 2005; 13: 241-54, v-vi.
10. Hahn PF, Saini S. Liver-specific MR imaging contrast agents. Radiol Clin North Am 1998; 36: 287-97.
11. Ji H, Ros PR. Magnetic resonance imaging. Liver-specific contrast agents. Clin Liver Dis 2002; 6: 73-90.
12. Bellin MF, Zaim S, Auberton E et al. Liver metastases: safety and efficacy of detection with superparamagnetic iron oxide in MR imaging. Radiology 1994; 193: 657-63.
13. Vogl TJ, Hammerstingl R, Schwarz W et al. Superparamagnetic iron oxide-enhanced versus gadolinium-enhanced MR imaging for differential diagnosis of focal liver lesions. Radiology 1996; 198: 881-7.
14. Sica GT, Ji H, Ros PR. Computed tomography and magnetic resonance imaging of hepatic metastases. Clin Liver Dis 2002; 6: 165-79, vii.
15. Wittenberg J, Stark DD, Forman BH et al. Differentiation of hepatic metastases from hepatic hemangiomas and cysts by using MR imaging. AJR Am J Roentgenol 1988; 151: 79-84.
16. Kelekis NL, Semelka RC, Woosley JT. Malignant lesions of the liver with high signal intensity on T1-weighted MR images. J Magn Reson Imaging 1996; 6: 291-4.
17. Yu JS, Rofsky NM. Hepatic metastases: perilesional enhancement on dynamic MRI. AJR Am J Roentgenol 2006; 186: 1051-8.
18. Semelka RC, Hussain SM, Marcos HB, Woosley JT. Perilesional enhancement of hepatic metastases: correlation between MR imaging and histopathologic findings-initial observations. Radiology 2000; 215: 89-94.
19. Soyer P, Gueye C, Somveille E, Laissy JP, Scherrer A. MR diagnosis of hepatic metastases from neuroendocrine tumors versus hemangiomas: relative merits of dynamic gadolinium chelate-enhanced gradient-recalled echo and unenhanced spin-echo images. AJR Am J Roentgenol 1995; 165: 1407-13.
20. Torres CG, Lundby B, Sterud AT, McGill S, Gordon PB, Bjerknes HS. MnDPDP for MR imaging of the liver. Results from the European phase III studies. Acta Radiol 1997; 38; 631-7.
21. Hamm B, Vogl TJ, Branding G et al. Focal liver lesions: MR imaging with Mn-DPDP - initial clinical results in 40 patients. Radiology 1992; 182: 167-74.
22. Baron RL, Peterson MS. Liver tumor detection: comparison of Gd-BOPTA-enhanced MR, contrast-enhanced CT, and CT arterial portography (abstract). Radiology 1995; 197: 415.
23. Caudana R, Morana G, Pirovano GP et al. Focal malignant hepatic lesions: MR imaging enhanced with gadolinium benzyloxypropionictetra-acetate (BOPTA) - preliminary results of phase II clinical application. Radiology 1996; 199: 513-20.
24. Reimer P, Rummeny EJ, Daldrup HE et al. Enhancement characteristics of liver metastases, hepatocellular carcinomas, and hemangiomas with Gd-EOB-DTPA: preliminary results with dynamic MR imaging. Eur Radiol 1997; 7: 275-80.
25. Vogl TJ, Kummel S, Hammerstingl R et al. Liver tumors: comparison of MR imaging with Gd-EOB-DTPA and Gd-DTPA. Radiology 1996; 200: 59-67.
26. Seneterre E, Taourel P, Bouvier Y et al. Detection of hepatic metastases: ferumoxides-enhanced MR imaging versus unenhanced MR imaging and CT during arterial portography. Radiology 1996; 200: 785-92.
27. Oudkerk M, van den Heuvel AG, Wielopolski PA, Schmitz PI, Borel Rinkes IH, Wiggers T. Hepatic lesions: detection with ferumoxide-enhanced T1-weighted MR imaging. Radiology 1997; 203: 449-56.
28. Hagspiel KD, Neidl KF, Eichenberger AC, Weder W, Marincek B. Detection of liver metastases: comparison of superparamagnetic iron oxide-enhanced and unenhanced MR imaging at 1.5 T with dynamic CT, intraoperative US, and percutaneous US. Radiology 1995; 196: 471-8.
29. Kim YK, Ko SW, Hwang SB, Kim CS, Yu HC. Detection and characterization of liver metastases: 16-slice multidetector computed tomography versus superparamagnetic iron oxide-enhanced magnetic resonance imaging. Eur Radiol 2006; 16: 1337-45.
30. Koh DM, Scurr E, Collins DJ et al. Colorectal hepatic metastases: quantitative measurements using single-shot echo-planar diffusion-weighted MR imaging. Eur Radiol 2006; 16: 1898-905.
31. Nasu K, Kuroki Y, Nawano S et al. Hepatic metastases: diffusion-weighted sensitivity-encoding versus SPIO-enhanced MR imaging. Radiology 2006; 239: 122-30.